Stocks:
5,169
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.09T
24h Vol:
$8.59B
Dominance:
MSFT:4.90%
Stocklytics Platform
CELG
Bristol-Myers Squibb Company Ce
CELG.RI
3
$0.04arrow_drop_down31.86%-$0.01
Penny Stock

Performance History

Chart placeholder
Key Stats
Open$0.05
Prev. Close$0.05
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap1024582008.00
PE Ratio-
LOWHIGH
Day Range0.04
0.05
52 Week Range0.03
0.14
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

info
There's no data available for Analyst Forecast

Analyst Ratings

info
There's no data available for Analyst Ratings

Correlated Companies

PRICE$321.47
24H (%)arrow_drop_down1.49%
24H ($)-$4.88
MARKET CAP$165.35B
PRICE$391.10
24H (%)arrow_drop_up2.08%
24H ($)$8.00
MARKET CAP$49.98B
Placeholder
PRICE$23.79
24H (%)arrow_drop_down1.89%
24H ($)-$0.46
MARKET CAP$37.02B
PRICE$23.25
24H (%)arrow_drop_down0.95%
24H ($)-$0.22
MARKET CAP$36.78B

About Bristol-Myers Squibb Company Ce (CELG.RI)

No data available
Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NYSE
add Bristol-Myers Squibb Company Ce to watchlist

Keep an eye on Bristol-Myers Squibb Company Ce

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Bristol-Myers Squibb Company Ce's (CELG.RI) price per share?

The current price per share for Bristol-Myers Squibb Company Ce (CELG.RI) is $0.04. The stock has seen a price change of -$0.02 recently, indicating a -31.86% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Bristol-Myers Squibb Company Ce (CELG.RI)?

For Bristol-Myers Squibb Company Ce (CELG.RI), the 52-week high is $0.14, which is 248.26% from the current price. The 52-week low is $0.03, the current price is 33.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Bristol-Myers Squibb Company Ce (CELG.RI) a growth stock?

Bristol-Myers Squibb Company Ce (CELG.RI) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bristol-Myers Squibb Company Ce as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Bristol-Myers Squibb Company Ce (CELG.RI) stock price performance year to date (YTD)?

As of the latest data, Bristol-Myers Squibb Company Ce (CELG.RI) has a year-to-date price change of .

help
Is Bristol-Myers Squibb Company Ce (CELG.RI) a profitable company?

Bristol-Myers Squibb Company Ce (CELG.RI) has a net income of , which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Furthermore, the EBITDA is $28.74B.

help
What is the market capitalization of Bristol-Myers Squibb Company Ce (CELG.RI)?

Bristol-Myers Squibb Company Ce (CELG.RI) has a market capitalization of $1.02B. The average daily trading volume is 76.48K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level